Search Results 851-860 of 18399 for Lactation

1. A Phase 2 Study of VLX-1005 Versus Placebo in Suspected Heparin Induced Thrombocytopenia - Mayo Clinic

   Pregnant or lactating women. 5. Have participated in any other investigational drug trial within 30 days of dosing or 5 half-lives (whichever is longer) in ...

2. Safety and Preliminary Efficacy of OBT076 in Recurrent/​Metastatic CD205+ Solid Tumors - Mayo Clinic

   Subject is lactating or breastfeeding. 16. Patient has a past medical history of or ongoing clinically relevant interstitial lung disease, drug-induced ...

3. A Study of the Effect of Relamorelin on Satiation, and on Gastric Volume, Accommodation and Function in Healthy Volunteers - Mayo Clinic

   Body mass index of 18-35 kg/m²; Female subjects must have negative urine pregnancy tests and must not be lactating prior to receiving study medication and ...

4. An Open-label Extension Trial of HZNP-HZN-825-301 in Adult Participants With Diffuse Cutaneous Systemic Sclerosis (Diffuse Cutaneous SSc) - Mayo Clinic

   Pregnant or lactating women. 6. Participants will be ineligible if, in the opinion of the Investigator, they are unlikely to comply with the trial protocol ...

5. Safety and Efficacy Study of PRI-724 Plus Gemcitabine in Subjects With Advanced or Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Women who are pregnant or lactating. Women of child-bearing potential (WOCBP) and fertile men with a WOCBP partner, not using adequate birth control ...

6. Dual BET And CBP/p300 Inhibitor In Patients With Targeted Advanced Solid Tumors And Hematological Malignancies - Mayo Clinic

   * Pregnant or lactating women * Known history of hepatitis B, hepatitis C requiring antiviral treatment * Human immunodeficiency virus (HIV)-infected ...

7. A Study of Momelotinib Versus Danazol in Symptomatic and Anemic Myelofibrosis Patients - Mayo Clinic

   Women who are already pregnant or lactating. Known intolerance or hypersensitivity to MMB or DAN, their metabolites, or formulation excipients. Patients ...

8. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

   * Lactating females are not eligible unless they have agreed not to breastfeed their infants starting with the first dose of study therapy through 5 months ...

9. A Study Comparing the Efficacy, Safety and Tolerability of Fixed Dose Combination (FDC) of FF/UMEC/VI With the FDC of FF/VI and UMEC/VI; Administered Once-daily Via a Dry Powder Inhaler (DPI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD) - Mayo Clinic

   Participation eligibility · Pregnancy: Women who are pregnant or lactating or are planning on becoming pregnant during the study · Asthma: Subjects with a current ...

10. Study of Endocrine Therapy With or Without Abemaciclib (LY2835219) Following Surgery in Participants With Breast Cancer - Mayo Clinic

    - Females who are pregnant or lactating. The participant has previously received treatment with any CDK4 and CDK6 inhibitor. The participant is receiving ...